Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000899923-25-000029
Filing Date
2025-04-09
Accepted
2025-04-09 16:08:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2024proxyadditiona.htm DEFA14A 8424
2 GRAPHIC myriadgeneticsinc_vxqmxnaxa.jpg GRAPHIC 178685
3 GRAPHIC pg2-myriadgeneticsinc_vxqma.jpg GRAPHIC 165731
  Complete submission text file 0000899923-25-000029.txt   483318
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 25825268
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)